What we do :
New Approach to Inflammatory Diseases (Small Molecule)-
Based on deep understanding of DAMPs (Damage Associated Molecular Patterns).
Targeting multi-modal, complex inflammatory diseases.
Developing immune modulating molecules with strong efficacy and excellent safety profiles.
Next Generation NanoMAb® Technology.
Based on a wide array of nanobody libraries from immunized camelid.
Focusing on new antigen ta...
What we do :
New Approach to Inflammatory Diseases (Small Molecule)-
Based on deep understanding of DAMPs (Damage Associated Molecular Patterns).
Targeting multi-modal, complex inflammatory diseases.
Developing immune modulating molecules with strong efficacy and excellent safety profiles.
Next Generation NanoMAb® Technology.
Based on a wide array of nanobody libraries from immunized camelid.
Focusing on new antigen targets.
Developing nanobody-based cancer therapeutics with high affinity and low immunogenicity.
From bispecific nanobodies to genetically conjugated Nanotoxin®.
High-throughput cell line development.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.